Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Hims & Hers Health, Inc. Revenue & Financial Statements
Hims & Hers Health, Inc. reported revenue of $2.3B for the fiscal year ended December 31, 2025, up 59.0% year over year, with net income of $128.4M and diluted EPS of $0.51.
- Company
- Hims & Hers Health, Inc. HIMS · NYSE
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 271.9M | 526.9M | 872.0M | 1.5B | 2.3B |
| Cost of revenue | 67.4M | 118.2M | 157.1M | 303.4M | 614.3M |
| Gross profit | 204.5M | 408.7M | 714.9M | 1.2B | 1.7B |
| Operating income | (115.0M) | (68.7M) | (29.5M) | 61.9M | 105.6M |
| Pretax income | (109.4M) | (62.5M) | (16.7M) | 71.1M | (10.3M) |
| Net income | (107.7M) | (65.7M) | (23.5M) | 126.0M | 128.4M |
| Diluted EPS | -0.58 | -0.32 | -0.11 | 0.53 | 0.51 |
| EBITDA | (111.0M) | (61.2M) | (19.9M) | 79.0M | 160.1M |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 278.2M | 315.6M | 401.6M | 481.1M | 586.0M | 544.8M | 599.0M | 617.8M |
| Cost of revenue | 49.1M | 59.0M | 83.7M | 111.6M | 155.3M | 128.6M | 156.9M | 173.4M |
| Gross profit | 229.1M | 256.6M | 317.9M | 369.5M | 430.7M | 416.2M | 442.1M | 444.4M |
| Operating income | 9.9M | 11.0M | 22.4M | 18.6M | 57.9M | 26.7M | 11.8M | 9.2M |
| Pretax income | 12.4M | 13.4M | 23.6M | 22.3M | 60.5M | 32.9M | 12.2M | 18.4M |
| Net income | 11.1M | 13.3M | 75.6M | 26.0M | 49.5M | 42.5M | 15.8M | 20.6M |
| Diluted EPS | 0.05 | 0.06 | 0.32 | 0.10 | 0.20 | 0.17 | 0.06 | 0.08 |
| EBITDA | 12.9M | — | 26.8M | 24.7M | 66.2M | — | 29.5M | 27.3M |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 420.6M | 366.3M | 441.2M | 707.5M | 2.2B |
| Current assets | 269.9M | 216.6M | 265.1M | 395.8M | 767.6M |
| Cash & equivalents | 71.8M | 46.8M | 96.7M | 220.6M | 228.6M |
| Total liabilities | 86.0M | 54.6M | 97.2M | 230.8M | 1.6B |
| Current liabilities | 79.2M | 47.9M | 88.5M | 221.4M | 404.4M |
| Long-term debt | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Stockholders’ equity | 334.6M | 311.7M | 344.0M | 476.7M | 540.9M |
| Net debt | — | — | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | (34.4M) | (26.5M) | 73.5M | 251.1M | 300.0M |
| Investing cash flow | (156.3M) | 34.7M | (12.1M) | (19.0M) | (1.0B) |
| Financing cash flow | 235.0M | (33.1M) | (11.5M) | (107.8M) | 729.6M |
| Capital expenditure | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 67.2M | 42.8M | 66.1M | 92.3M | 135.2M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every HIMS filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.